Skip to main content
All blogsClinical

Sermorelin Tablets: Do Oral and Sublingual Work?

Tablets, troches and sublingual drops all promise sermorelin without the needle. This page does what the product listings do not: it goes to the published record, reports exactly what is in it, and explains what a 3,358-dalton peptide is up against on each route.

PeRx PeptidesReviewed by Dr. Cory Mellon, MD16 min readPublished
Tablets are what thousands of people search for every month. Whether a 29-amino-acid peptide survives that route is the question nobody selling them answers.
Tablets are what thousands of people search for every month. Whether a 29-amino-acid peptide survives that route is the question nobody selling them answers.

Key Takeaways

  • As of September 2026, a PubMed search for sermorelin alongside oral, sublingual, troche, tablet or capsule returns zero results. The search is in this article so you can run it yourself. Every sermorelin tablet and troche on sale is being sold ahead of its evidence, not behind it.
  • Sermorelin is a 29-amino-acid chain weighing 3,358 daltons. That is roughly three times the size of octreotide, the peptide the pharmaceutical industry did successfully move into a capsule, and it took an enteric coating, a permeability enhancer and a Phase III program to get there.
  • The molecule is fragile by nature, not just in the gut. The FDA label for Geref, the approved injectable version, put the mean absolute bioavailability of a subcutaneous dose at about 6%, and the half-life at 11 to 12 minutes.
  • That 6% figure is the real argument, and not in the direction most people expect. The point is not that it is low. The point is that somebody measured it in 12 volunteers and published it. No equivalent number exists for any troche.
  • Route suitability is specific to the molecule, not a rule about peptides. Oral BPC-157 capsules are a legitimate product because that peptide is unusually stable in the stomach and its target is the gut lining itself. Sermorelin has neither property.
  • PeRx prescribes sermorelin as a subcutaneous injection only, $229 for a one-month supply. There is no oral, sublingual or nasal sermorelin here, and this page explains the reasoning rather than routing around the question.

Oral Sermorelin at a Glance

Molecule

29 amino acids, 3,358 daltons, formula C149H246N44O42S

Published oral or sublingual studies

None indexed on PubMed as of September 2026

What the FDA label measured

About 6% absolute bioavailability, subcutaneous, in 12 volunteers

Half-life

11 to 12 minutes, the same by vein or under the skin

Route of the approved product

Injection. Both Geref approvals were injections, withdrawn in 2009

What PeRx prescribes

Subcutaneous injection only, 20 units at bedtime, $229 per month

Do Sermorelin Tablets Work?

Nobody knows, and that is the honest answer rather than a dodge. No published human study has measured whether a swallowed sermorelin tablet, a sublingual troche or a dissolvable strip puts any meaningful amount of intact sermorelin into the bloodstream. Products exist, some are dispensed by licensed compounding pharmacies with real prescriptions behind them, and patients report feeling better on them. What does not exist is a measurement.

That gap matters more for this molecule than for most, because sermorelin is unusually fragile even when you inject it. The rest of this page lays out the pharmacology, the exact literature search, and what a buyer can reasonably do with all of it. If you are looking for the injectable protocol instead, the sermorelin dosage chart has it.

Why PeRx Is Answering a Question About a Product It Does Not Sell

We prescribe sermorelin as an injection and nothing else, which gives us an obvious interest in the answer. So rather than assert a conclusion, this page shows the searches, the label figures and the sources, and you can check every one of them.

What the Published Record Contains

Start with the size of the whole field. Searching PubMed for sermorelin in the title or abstract returns 24 records, checked in September 2026. That is the entire indexed literature carrying the drug name prominently, across 35 years. Most of it is analytical chemistry written for anti-doping laboratories: methods for detecting growth hormone releasing hormone analogs in urine and blood. Two are clinical reviews. One is a case report.

Now narrow it to the route. Pair sermorelin with oral, with sublingual, with troche, tablet or capsule, or with bioavailability, and every one of those searches returns nothing at all. Not a small study, not an animal study, not a pharmacokinetic letter.

Run the Search Yourself

sermorelin[Tiab] AND oral[Tiab]

0 results

sermorelin[Tiab] AND sublingual[Tiab]

0 results

sermorelin[Tiab] AND (troche[Tiab] OR tablet[Tiab] OR capsule[Tiab])

0 results

sermorelin[Tiab] AND bioavailability[Tiab]

0 results

sermorelin[Tiab], the whole field

24 results, mostly doping-control assay development

Paste any of those into the PubMed search box. Counts change as papers are indexed, and if that first line ever returns something, this page should be updated. As of writing it does not. A 2026 review in Frontiers in Endocrinology arrives at the same place from a different direction: it sorts the growth hormone axis peptides into evidence tiers running from regulatory-grade randomized trial data down to a complete absence of human studies, and its whole premise is the distance between what the literature supports and what circulates in online self-administration protocols.

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M. "The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration." Frontiers in Endocrinology. 2026;17:1822475. View study

One more thing worth knowing. The paper most often cited as the reference for adult sermorelin is a two-page piece from 2006 in Clinical Interventions in Aging. It is a commentary rather than a trial, and it closes by offering free sermorelin to practitioners willing to study it. A legitimate opinion piece, and not evidence that a tablet absorbs.

Why Sermorelin Is Hard to Absorb

Two separate problems stack up here, and most pages only mention the first one.

The gut problem. Sermorelin is a chain of 29 amino acids. Your digestive tract runs on enzymes whose specific job is cutting chains of amino acids into pieces small enough to absorb. Swallowing a peptide feeds it to the machinery built to dismantle it. This is the general obstacle across the whole class, described plainly in a 2020 review in Nature Reviews Drug Discovery: peptide therapeutics require injection, oral delivery faces substantial barriers tied to how the gastrointestinal tract is organized, and getting around those barriers takes permeation enhancers, enzyme inhibitors or engineered carrier peptides.

Drucker DJ. "Advances in oral peptide therapeutics." Nature Reviews Drug Discovery. 2020;19(4):277-289. View study

The fragility problem. This one is specific to sermorelin and it is the more interesting half. The molecule is short-lived once it is in you, by any route. Chemists at Serono, the company that made the approved product, published on exactly this: the main drawback of using GRF(1-29) as a drug is a plasma half-life of roughly 10 to 20 minutes in humans, driven by filtration at the kidney and by enzymes chewing the chain from its N-terminal end. Their answer was to attach polyethylene glycol to the peptide to slow that destruction down, and they tested those conjugates by vein and under the skin.

Esposito P, Barbero L, Caccia P, et al. "PEGylation of growth hormone-releasing hormone (GRF) analogues." Advanced Drug Delivery Reviews. 2003;55(10):1279-1291. View study

Read that again with an eye on what is missing. The manufacturer knew its peptide was fragile, invested real chemistry in fixing it, and never went looking for an oral version. The engineering effort went into making an injection last longer.

The 6% Number, and What It Actually Argues

The clinical pharmacology section of the Geref label reports that 2 mg of sermorelin was given subcutaneously to 12 normal volunteers. Peak concentrations arrived in 5 to 20 minutes, and the mean absolute bioavailability of that subcutaneous dose was about 6%. Absolute bioavailability compares a route against an intravenous dose, so roughly 94% of an injection never arrives intact. Clearance ran 2.4 to 2.8 litres per minute.

That is low for an injected peptide, and it is a measurement of the molecule rather than a criticism of the needle. The approved dose was set with the loss already priced in. The reason it belongs on a page about tablets is the comparison it sets up: for the injection, twelve people were dosed and the fraction was published. For a troche, nobody has run the equivalent study, so the honest comparison is not a high number against a low one. It is a measured number against no number.

GEREF (sermorelin acetate for injection) prescribing information, Serono Laboratories. Description and Clinical Pharmacology sections, as archived by RxList. View study

Tablets, Troches, Sprays: Format by Format

The formats are not equivalent to each other. Here is each one on its own terms.

Swallowed tablet or capsule

The idea behind it
Convenience. Absorbed through the intestinal wall like any oral drug
What is published for sermorelin
Nothing. The peptide also has no gut-local target to act on along the way

Sublingual troche or tablet

The idea behind it
Dissolve under the tongue, cross the mucosa, skip the stomach and the liver
What is published for sermorelin
Nothing. The route is real pharmacology, but permeability falls steeply with molecular size

Nasal spray

The idea behind it
Thin, blood-rich nasal tissue. Several peptide hormones are marketed this way
What is published for sermorelin
A 1998 review listed GHRH among the intranasal peptides never brought to market

Subcutaneous injection

The idea behind it
Deposit under the skin, absorb into blood and lymph, bypass digestion entirely
What is published for sermorelin
About 6% absolute bioavailability, measured in 12 volunteers for the approved product

The sublingual row deserves the most care, because it is the format with the strongest theoretical case and it is where the better sellers have moved. Absorption under the tongue is genuine pharmacology. The tissue is thin and sits over a dense bed of vessels, and anything crossing it enters circulation without passing through the liver. The catch is that permeability drops sharply as molecules get larger, and sermorelin at 3,358 daltons sits far up that curve. Our sublingual peptides guide works through the size rules in detail and reaches the same conclusion about the growth hormone peptides as a group.

There is also a practical problem nobody advertises. Sublingual absorption is a race against your own swallowing reflex, and whatever goes down the throat before it crosses the mucosa becomes an ordinary oral dose, back in front of the digestive enzymes.

On the nasal route, a 1998 review of peptide hormones by nasal delivery is instructive. It names the peptides that made it to market that way, including desmopressin, oxytocin and salmon calcitonin, and then lists the ones that had not, with GHRH on that second list. Nearly thirty years later it is still there. Its opening line is the general rule: peptide hormones cannot be given by mouth, because they are digested and inactivated in the gastrointestinal tract and then hit significant first-pass metabolism in the liver.

Pontiroli AE. "Peptide hormones: Review of current and emerging uses by nasal delivery." Advanced Drug Delivery Reviews. 1998;29(1-2):81-87. View study

What Making a Peptide Oral Actually Takes

The best way to judge a compounded sermorelin troche is to look at what the pharmaceutical industry had to do when it genuinely solved this problem for another peptide. Octreotide is the clearest case. It is eight amino acids weighing about 1,019 daltons, roughly a third the size of sermorelin, and it had the same obstacle: it worked by injection and patients disliked the injections. The oral version that reached the clinic combines an enteric coating, so the capsule survives the stomach and releases in the small intestine, with a transient permeability enhancer that briefly opens the intestinal wall to let the peptide through. Twice-daily oral dosing reaches octreotide levels comparable with 100 micrograms given subcutaneously, and that conclusion rests on Phase III trials followed by durability data out to three years.

McLaren DS, Seejore K, Lynch J, Murray RD. "Oral Octreotide Capsules and Paltusotine in Management of Acromegaly." touchREVIEWS in Endocrinology. 2024;20(1):32-36. View study

Oral semaglutide tells the same story in a different molecule. It is an approved product, and it is approved because it is co-formulated with an absorption enhancer that carries it across the stomach lining, not because somebody discovered semaglutide absorbs on its own.

Set a compounded sermorelin troche next to either of those. It is a larger molecule than octreotide, it typically has no permeability enhancer, no enteric engineering, no pharmacokinetic study, and no clinical program. It is a peptide in a pleasant-tasting base. That is not an accusation of bad faith, and the pharmacies making these preparations are following prescriptions in the ordinary way. It is a statement about what has and has not been demonstrated.

Where Oral Peptides Genuinely Do Work

A page like this can slide into a blanket claim that oral peptides are a scam, and that claim is wrong. Route suitability belongs to the specific molecule and its target, not to the category. PeRx sells an oral peptide product, which would be indefensible if the blanket version were true.

BPC-157 capsules work for two reasons that sermorelin cannot borrow. The peptide was derived from a protein found in human gastric juice, so it is unusually stable in the exact environment that destroys most peptides. And for gut protocols the target tissue is the stomach and intestinal lining itself, which means contact happens before absorption is even the question. A peptide that only needs to touch the gut does not have the same problem as one that has to reach the pituitary. The BPC-157 route comparison covers where that argument holds and where it stops.

Sermorelin has neither property. It is not stable in the stomach, and its target is a gland at the base of the brain that it can only reach through the bloodstream. The general version of this trade-off, across the catalog, is in our oral vs injectable peptides guide.

Consider alternatives if

Think harder if: needle aversion is severe enough that you would not start at all. The honest comparison then is an unproven route against no treatment, and that conversation belongs with a clinician who knows your history. Neither route fits if: you have an active or recent cancer, are pregnant or breastfeeding, or compete in a drug-tested sport.

Questions to Ask Before You Buy

If you are going to buy an oral or sublingual sermorelin product anyway, and people will, these are the questions that separate a real pharmacy preparation from a bottle of something. The answers are also a fast way to tell whether a seller has thought about any of this.

Six Questions Worth Asking

What is the route and the dose, in micrograms?

A listing that names a format without a strength is not describing a medicine. Doses set for one route do not transfer to another.

Is there published human absorption data for this route?

For sermorelin by mouth or under the tongue, the answer in September 2026 is no. A seller who says otherwise should be able to name the study.

What does the testing cover, the raw powder or the finished product?

Identity and potency on an incoming powder says nothing about how much survives in the finished troche. How to read a peptide COA explains the difference.

Is this a patient-specific prescription from a licensed pharmacy?

A compounded preparation is dispensed against a prescription after a provider reviews your history. Anything sold as research material is not that.

What is the beyond-use date, and how is it stored?

Peptides degrade. A compounded preparation should carry a dated label and storage instructions, the same as any other prescription.

Who is accountable if something goes wrong?

The gap between a prescription and an online purchase is mostly a gap in accountability. Research vs prescription peptides covers what that difference is worth.

The Amazon Listing

One of the top ten results for sermorelin tablets is an Amazon listing selling sermorelin as laboratory research material. Sermorelin is a prescription drug substance. A product sold without a prescription, labelled for research, carries no assurance of identity, purity, sterility or dose, and the seller is not claiming it is a medicine. Is it safe to buy peptides online goes through how to tell these apart.

What the Injection Actually Involves

Most people searching for a sermorelin pill are not making a pharmacology argument. They are trying to avoid a needle, often picturing something from a doctor's office decades ago.

The PeRx protocol is 20 units on a U-100 insulin syringe, which is 0.2 mL, or 600 micrograms, into the fat layer of the abdomen or thigh at bedtime, Monday through Friday, at least two hours after eating. The needle is 29 to 31 gauge, thinner than the ones used for blood draws, and the whole business takes about ten seconds. Most people describe it as a pinch or as nothing at all. The vial ships fully reconstituted and ready to use, so there is no mixing and no measuring beyond lining up a mark on a syringe. Our injection site guide maps the rotation, and how to take peptides covers technique across the catalog.

The bedtime timing is not arbitrary either, and it is a detail the oral formats tend to lose. The largest natural growth hormone pulse in adults comes with the first stretch of deep sleep, and the dose is timed to land on top of it.

Sermorelin

One vial, 3 mg per mL, 5 mL, compounded by a licensed US 503A pharmacy against a prescription written after a provider reviews your intake. At 20 units a night, five nights a week, a vial is 25 doses. It arrives cold with syringes and alcohol swabs in the box and nothing to prepare.

Compounded sermorelin is not Geref and has not been through FDA review, which is worth stating on a page built around what has and has not been demonstrated. $229 for a one-month supply, charged only if a provider approves the prescription.

PeRx sermorelin vial for subcutaneous injection

The route with a published absorption figure behind it.

View Sermorelin

Sermorelin Tablets: Common Questions

PeRx ships sermorelin fully reconstituted and ready to use. Store it in the refrigerator at 36-46 degrees Fahrenheit (2-8 degrees Celsius). Do not freeze reconstituted sermorelin. Keep the vial upright and away from light. Before each use, visually inspect the solution. It should be clear and colorless. If you see particles, cloudiness, or discoloration, do not use it. Reconstituted sermorelin is generally stable for several weeks when stored properly and handled with clean technique. Troches and tablets from other sellers follow different storage rules, and a compounded preparation should arrive with its own dated instructions.

Compounding pharmacies do prepare sermorelin as tablets, capsules and sublingual troches, and some telehealth clinics prescribe them, so the products are real. What does not exist is a published study showing how much of a dose gets into circulation by those routes. No sermorelin product in any oral form has been approved by the FDA. The two approvals that did exist, both under the Geref name, were injections, and both were withdrawn in 2009.

On evidence, the injection, because it is the only route anyone has measured. The label for the approved injectable product reports about 6% absolute bioavailability from a subcutaneous dose in 12 volunteers, which is a modest figure but a real one, and the prescribed dose accounts for it. For tablets and troches there is no comparable measurement at all. If a needle is the reason you are asking, that is a fair reason, and it is worth raising directly with a clinician rather than solved by assuming a troche is equivalent.

In principle yes, since the sublingual route skips stomach acid and first-pass liver metabolism, and that is why most serious sellers have moved to troches rather than swallowed pills. In practice the gain is unquantified for this molecule. Permeability under the tongue falls steeply as molecules get bigger, and at 3,358 daltons sermorelin is well above the size where passive absorption is reliable. Whatever you swallow before it dissolves becomes an ordinary oral dose.

Other compounders offer one. PeRx does not carry a nasal spray, nasal drops or any intranasal product, for sermorelin or anything else in the catalog. The nasal route is plausible chemistry and several peptide hormones are marketed that way, but GHRH was named on a 1998 review's list of intranasal peptides that had not been brought to market, and it is still not there. As with troches, the honest description is an untested route rather than a proven one.

Compounding operates on a different basis from drug approval. A pharmacy prepares a medication for an individual patient against a prescription, and the preparation itself is not required to carry the clinical trial package an approved drug does. That is what compounding is for, and it is why the option exists. It also means the absence of evidence for a route is not a barrier to a product existing, so the buyer has to ask the question the approval process would otherwise have asked.

No. Geref and Geref Diagnostic were approved injections, discontinued by the manufacturer in 2008 with the approvals withdrawn effective June 18, 2009. The FDA determined in 2013 that they had not been withdrawn for reasons of safety or effectiveness. Compounded sermorelin today, by any route, has not been through FDA review, and the regulatory picture for compounded peptides more broadly remains unsettled. Our sermorelin FDA status guide has that history.

Several things can be true at once. Sleep and energy fluctuate on their own, expectation is a powerful driver of perceived benefit, and any product taken at bedtime inherits credit for a good night. It is also possible that some fraction absorbs and nobody has measured it. That is the genuinely open part. What cannot be concluded from feeling better is that a specific amount of peptide reached the pituitary, which is why the measurement matters.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Ready to get started?

Pharmacy-compounded sermorelin, prescribed by a licensed provider after a health review, shipped fully reconstituted and ready to use with everything you need.

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.